← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2005Last known activity
Aug 23, 2017
Timeline
2000s
- Jan 1, 2003
Mid-Atlantic Epilepsy and Sleep Center— Founded
Drugs by trial phase (7 distinct, 6 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (14)
- NCT03288129Overall official - principal investigatorPhase 4Aug 23, 2017
- NCT02727101Overall official - principal investigatorPhase 4Nov 1, 2015
- NCT02727101Lead sponsorPhase 4Nov 1, 2015
- NCT02727101Reponsible party - principal investigatorPhase 4Nov 1, 2015
- NCT02726919Lead sponsorPhase 4Feb 1, 2015
- NCT02726919Overall official - principal investigatorPhase 4Feb 1, 2015
- NCT02726919Sponsor investigatorPhase 4Feb 1, 2015
- NCT02726867Reponsible party - principal investigatorPhase 3Feb 1, 2014
- NCT02726867Lead sponsorPhase 3Feb 1, 2014
- NCT02726867Overall official - principal investigatorPhase 3Feb 1, 2014
- NCT02069197Reponsible party - principal investigatorPhase 2Jan 1, 2014
- NCT02069197Overall official - principal investigatorPhase 2Jan 1, 2014
- NCT02069197Lead sponsorPhase 2Jan 1, 2014
- NCT01463033Lead sponsorPhase 2Apr 1, 2005
Details
- Founded
- Bethesda, MD, US Jan 1, 2003
- Last known activity
- Aug 23, 2017